Allied Academies is an established and reputed publisher which started publishing in the year 1994. The Allied Academics play a major role in imparting knowledge and keep one aware of the new trends in the different areas of study through journals and conferences. In this journey of publishing, the publisher received several awards and accolades for dedicated service and strictly considering ethical practices. Allied Academies has become an obvious choice for the researchers and academicians to showcase their excellent contributions. The publisher provides authors and readers a complete platform to share their work with the global community.
Allied Academic proudly announces “4th International Conference on Obesity & Weight Management” scheduled on April 17-18, 2019 Rome, Italy. The theme of the meeting is "Nutrition against obesity: Fight for fat to fit".
Euro Obesity 2019 the main objective of the event is to promote awareness about proper nutrition and risk associated with improper diet along with obesity and its impact on health, Euro Obesity 2019 will educate and strengthen recent research on the several causes, results, treatment, and prevention of obesity. It includes a wide range of Keynote presentations, Oral talks, Poster presentations, Symposia, Workshops, Exhibitions and Career development programs.
In addition to attending the conference, we invite you to experience Rome, the beautiful and famous city in Italy, which attracts people from around the world.
Track 1: Obesity and weight management
Obesity Management includes lifestyle changes, medications, or surgery and the main treatment for obesity consists of dieting and physical exercise. Knowing what your body desires is very important to weight management and may control overconsumption and under consumption of food. Weight management doesn't include fad diets that promote fast, temporary weight loss. It focuses on the long-term results that are achieved through slow weight loss, followed by retention of an ideal weight for age, sex and height. . Diet programs may produce weight loss over the short term period, but maintaining this weight loss is frequently difficult and often requires making exercise and a lower calorie diet a permanent part of an individual's lifestyle.
• Abnormal obesity
• Dietary Supplements
• Metabolic Outcomes
• Pharmacologic Therapy
• A diet high in simple carbohydrates
• Frequency of eating
• Physical inactivity
• Psychological factors
Track 2: Diabetes and obesity
• type 2 diabetes
• Gestational diabetes
Track 3: Obesity, high cholesterol and metabolic syndrome
• High Blood Sugar
• High Triglycerides Levels
• Low HDL Levels
• High Blood Pressure
• Esophageal adenocarcinoma
• Gastric cardia cancer
• Liver cancer
• Kidney cancer
• Multiple myeloma
• Pancreatic cancer
• Colorectal cancer
• Gallbladder cancer
• Breast cancer
Track 5: Clinical diabetes
Novel therapeutic mark available for diabetes includes Incretin based therapies, oral therapeutic agents likes secretagogues, beta cell regeneration & proliferation and stem cell therapies. Embryonic stem cell and fetal precursor cell transplantation therapies are the major stem cell therapies available for Diabetes. Aside from the above, various computational approaches in Diabetes management have been introduced recently with latest diabetes clinical trial going on which are playing an important role in identification of genes causing diabetes helping in Early Detection of Diabetes. These actions are also useful in studying the chemical etiologies of Diabetes uncovering various treatment prospects and model construction processes for survival prediction combating the complications of diabetes like Gestational Diabetes, Diabetes Myopathy, Diabetes cardiopathy and more.
Track 6: Obesity in Cardiovascular diseases
Track 7: Childhood Diabetes & Obesity
• Birth weight
• Infant Feeding
Track 8: Eating Disorders
Track 10: Genetics and Transplantation of Diabetes
• Diabetes in specific ethnic groups
• Recent advances in genetics of diabetes
• Pancreatic islet transplantation
• Conventional insulinotherapy
• Genetics of Type 2 Diabetes: From Candidate Genes to Genome-Wide Association Analysis
Track 11: Endocrinology Disorders and Treatment
Endocrine disorder that results when a gland produces too much or too little of an endocrine hormone, called a hormone imbalance. The endocrine system is a network of glands that produce and release hormones that help control many important body functions, including the body's ability to change calories into energy that powers cells and organs. The endocrine system influences how heart beats, how bones and tissues grow, even ability to make a baby. It plays a vital role in whether or not develops diabetes, thyroid disease, growth disorders, sexual dysfunction, and a host of other hormone-related disorders.
Each gland of the endocrine system releases specific hormones into bloodstream. These hormones travel through blood to other cells and help control or coordinate many body processes.
• Endocrine glands include:
• Adrenal glands
• Islet cells in the pancreas
• Pineal gland
• Pituitary gland
Track 12: PCOS, obesity and infertility
Obesity during pregnancy increase the risk of various pregnancy complications, including:
• Gestational diabetes
• A pregnancy complication characterized by high blood pressure and signs of damage to another • organ system, often the kidneys (preeclampsia)
• Cardiac dysfunction
• Sleep apnea
• A difficult vaginal delivery
Track 13: Obesity Medication & Newer drugs to treat obesity
Advanced interpretation and distinguishing tactics for obesity is needed that it should be applicable, medically meaningful, and adds value to the health-promoting effects of weight loss. A conscious target is to start dynamic lifestyle changes by creating physical activity and consumption sound sustenance.
• Gastric Bypass surgery
• Morbid obesity treatment
• Sympathomimetic drugs
• Surgical and Non-Surgical Liposuction
• Morbid Obesity Treatment
• Advanced Inch loss Therapy
• Sleeve Gastrectomy
• Islet Cell Transplantation
14.1 Intragastric Balloon Therapy
• Warrior pose
Track 16: Statins in favour of diabetes
• A diagnosis of cardiovascular disease
• An LDL cholesterol level of 190 mg/dL or higher
• Diabetes and an LDL of 70 mg/dL or higher
• A 10-year heart attack risk of 7.5 percent or higher and an LDL of at least 100 mg/dL
In 2017, the American Diabetes Association recommended that all people with diabetes take statins. Their reasoning is that controlling risk factors will help lower your overall risk for developing heart disease. These risk factors may include:
• High cholesterol
• High blood pressure
• being overweight or obese
• A high level of sodium in your diet
• A low level of physical activity
The fewer risk factors you have, the better your odds of avoiding a heart attack or stroke.
• Macronutrients and Micronutrients
• Calorie Counting
• Nutrient profiling
• Nutrition Disorders
• Different types of Diet plans
Track 17: Bariatric and liposuction
Track 19: Obesity Counselling
About Euro Obesity 2019
Allied Academies is an
established and reputed publisher which started publishing in the year 1994.
The Allied Academics play a major role in imparting knowledge and keep one
aware of the new trends in the different areas of study through journals and
conferences. In this journey of publishing, the publisher received several
awards and accolades for dedicated service and strictly considering ethical
practices. Allied Academies has become an obvious choice for the researchers
and academicians to showcase their excellent contributions. The publisher
provides authors and readers a complete platform to share their work with the
The primary focus is to publish original research work with high standard and novelty along with other types of articles including review articles, short communication, Editorial, case reports, Commentary, Perspectives etc. Authors are being requested to follow individual journal guidelines for further specifications.
4th International Conference on Obesity and Weight Management welcomes all the participants around the globe to be a part of the event during April 17-18, 2019 at Rome, Italy. The theme of the meeting is “Nutrition against obesity: Fight for fat to fit”
Euro Obesity Congress the main objective of the event is to promote awareness about proper nutrition and risk associated with improper diet along with obesity and its impact on health, Euro Obesity 2019 will educate and strengthen recent research on the several causes, results, treatment, and prevention of obesity, Event like our's is essential to encourage the involvement of researchers, scientists and to highlight their role, this will help to Connect active researchers and practitioners from diverse disciplines.
Euro Obesity Conference is focused in improving the lives of those living with obesity, cherishing careers of obesity scientists and practitioners and promoting the interdisciplinary nature of obesity research, management and education.
Euro Obesity Summit is a step to achieve the principal breaches in the revolution of this science of hope, to serve promptly with resolutions to all in the need. Euro Obesity meeting will have an anticipated participation of 150+ delegates across the world to discuss the conference goal.
Scientists, Doctors, Professors, Practitioners, Therapists, Business/Practice Managers, Health Professionals, Students, and Young researchers, Associations, Societies and Universities.
Disorders that may occur with obesity are Diabetes type 1and Diabetes type 2, asthama, sleep apnea, cardiovascular issues and orthopaedic problems. Almost 35% of the adults with income lower than $15000 per year are obese. 24% adults with income higher than $50000 per year are obese. Global Anti-obesity Drugs market is expected to grow at a CAGR of 39.45 percent over the period 2014-2019.
Increment in the wellbeing issues, modern lifestyle and nearness of enormous number of obese populace over the globe is the driving element for the worldwide hostile to corpulence drug market. . The market is segmented by the product type and end user. The worldwide anti-obesity drug business sector is relied upon to develop at CAGR of 40% over the time of 2015-2020.The worldwide anti- obesity drug business sector is required to extend locally by North America, Europe and Asia pacific. The worldwide obesity surgery gadget business sector is relied upon to develop at a CAGR of 9.6% from 2014-2020 to come to an expected estimation of USD 2489.5 million in 2020 from USD 1432.4 in 2014 .North America is the biggest business sector for worldwide weight surgery devices took after by Europe.
Italy is well-known for its healthy way of life and Mediterranean diet – but the country is facing severe future health problems because of its overweight children. As indicated by the OECD information, Greece has the most astounding rate of overweight and obese kids (5-17 aged) on the globe, followed by Italy, U.S. furthermore, Mexico. Italy's younger generation are increasingly eating more processed foods, more fast foods and more sugary desserts and beverages. A striking example of this can be seen in an aggressive publicizing effort dispatched by Coca-Cola in Italy in 2011.
Childhood Obesity rates are extremely considered one of the highest (36% for boys and 34% for girls) In addition, WHO projections forewarn that by 2030 rising prevalence could see sickness rates almost twofold for specific populaces. In a country renowned for its regional variations in cuisine, Italians try not to take after an unbending arrangement of eating traditions, making it less demanding for commercial food advertisers to exploit. Considering the above criteria Italy would be the finest places for a conference on Obesity.
As indicated by the OECD
information, Greece has the most astounding rate of overweight
and obese kids (5-17 aged) on the globe, followed by Italy,
U.S. furthermore, Mexico.
Anti-obesity drug Growth
by next 12 years
The anti-obesity drug market development will be driven by the quick uptake of novel rising specialists and the high pervasiveness of weight. As indicated by Global Anti-Obesity Drugs Market 2015-2019 exploration, the worldwide anti-obesity drugs business sector is set to develop at a CAGR of 39.45% over the period 2014-2019 Presently, the weight drug market comprises of not very many compelling medications, with constrained accessibility in various locales that is accessible in both the EU and the US. . U.S. is relied upon to burn through $344 billion on human services costs owing to heftiness in 2018 if rates keep on increasing at their present levels. The stoutness drug business sector will expand more than six-fold throughout the following decade, expanding from $420 million in 2010 to rate will reach at least 44% by 2030 in the United States, France, Germany, Italy, Spain, the UK and Japan.